TZT is a safe agent with a low risk of hypoglycemia
Liver pathology and cognitive impairment Cognitive impairment, a hallmark of AD, has strong links to metabolic alterations in the liver
Currently, the efficacy estimand for injectable semaglutide demonstrates greater weight loss compared to the available oral tablet
Some people may experience: Injection site reactions Headache Dizziness Fatigue Serious side effects are rare but may include: Allergic reactions Pancreatitis (inflammation of the pancreas) Risk to unborn babies Low blood sugar, especially when combined with insulin or other diabetes medications Yes
Yildirim M, Inaloz HS, Baysal V, Delibas N
A Randomized Controlled Trial of an Intensive Insulin Regimen in Patients With Hyperglycemic Acute Lymphoblastic Leukemia